BiotechTube
Home/CiVi Biopharma/Christopher Fuglesang
CF

Christopher Fuglesang

Chairman of the Board

CiVi Biopharma

Therapeutic Areas

CardiovascularMetabolicOrphan Diseases

CiVi Biopharma Pipeline

DrugIndicationPhase
CiVi 030Severe FrostbitePhase 3
CiVi 008Hypercholesterolemia and Prevention of Atherosclerotic Cardiovascular Disease (ASCVD)Pre-clinical

Leadership Team at CiVi Biopharma

SJ
Shal Jacobovitz
Chief Executive Officer
HØ
Henrik Ørum
Founder, Chief Scientific Officer
CS
Chuck Shear
Chief Development Officer
WB
Wade Benton
Chief Development Officer, Orphan Drugs
View full CiVi Biopharma profile